AUGMEDIX INC (AUGX)

Company Profile

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 1,040 full-time employees. The company went IPO on 2021-03-04. The firm uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. The company also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Company Info

AUGMEDIX INC

111 Sutter Street, Suite 1300, Suite Ll

San Francisco CALIFORNIA

P: 15619892208

CEO: Emmanuel Krakaris

Employees: 1040

Website: https://augmedix.com/